Skip to main content

Provectus Pharmaceuticals, Inc. (OTC:PVCT) Investor Files Lawsuit Over Alleged Breaches Of Fiduciary Duties In Connection With Certain Executive Compensation

  • If you are acurrent long-term stockholder of shares of Provectus Pharmaceuticals, Inc. (OTC:PVCT), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

Jan. 15, 2013 (Shareholders Foundation) -- An investor in shares of Provectus Pharmaceuticals, Inc. (OTC:PVCT) filed a lawsuit against directors of Provectus Pharmaceuticals, Inc. over alleged breaches of fiduciary duties in connection with certain compensation that was awarded to certain executives at Provectus Pharmaceuticals, Inc. The plaintiff alleges that Provectus Pharmaceutic...



You must register (for free) or login to view the entire case.